The global market for ADCC Enhanced Antibody was valued at US$ 12300 million in the year 2024 and is projected to reach a revised size of US$ 17190 million by 2031, growing at a CAGR of 4.9% during the forecast period.

ADCC Enhanced Antibody Market

ADCC enhanced antibody refers to an antibody that enhances antibody-dependent cell-mediated cytotoxic effects (ADCC) by modifying or optimizing the Fc segment of the antibody to improve its affinity with the surface of immune cells FcγR. This enhanced ADCC effect allows immune cells to more effectively recognize and kill target cells labeled by antibodies, such as tumor cells or virus-infected cells, thereby enhancing the therapeutic effectiveness of antibody drugs.

North American market for ADCC Enhanced Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for ADCC Enhanced Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of ADCC Enhanced Antibody include MacroGenics, Roche Holding AG, Novartis AG, C.H. Boehringer Sohn, Puma Biotechnology, Pfizer, Daiichi Sankyo, Takeda Pharmaceutical, Jazz Pharmaceuticals, Merus NV, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for ADCC Enhanced Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ADCC Enhanced Antibody.

The ADCC Enhanced Antibody market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global ADCC Enhanced Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the ADCC Enhanced Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of ADCC Enhanced Antibody Market Report

Report Metric	Details
Report Name	ADCC Enhanced Antibody Market
Accounted market size in year	US$ 12300 million
Forecasted market size in 2031	US$ 17190 million
CAGR	4.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Monospecific Antibody Polyspecific Antibody Fc Fusion Protein Antibody Fusion Protein
Segment by Application	Hospital Clinic Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	MacroGenics, Roche Holding AG, Novartis AG, C.H. Boehringer Sohn, Puma Biotechnology, Pfizer, Daiichi Sankyo, Takeda Pharmaceutical, Jazz Pharmaceuticals, Merus NV, Hengrui Medicine, Sansheng Guojian, RemeGen Biopharma, Dizal (Jiangsu) Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of ADCC Enhanced Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of ADCC Enhanced Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is ADCC Enhanced Antibody Market growing?

Ans: The ADCC Enhanced Antibody Market witnessing a CAGR of 4.9% during the forecast period 2025-2031.

What is the ADCC Enhanced Antibody Market size in 2031?

Ans: The ADCC Enhanced Antibody Market size in 2031 will be US$ 17190 million.

Who are the main players in the ADCC Enhanced Antibody Market report?

Ans: The main players in the ADCC Enhanced Antibody Market are MacroGenics, Roche Holding AG, Novartis AG, C.H. Boehringer Sohn, Puma Biotechnology, Pfizer, Daiichi Sankyo, Takeda Pharmaceutical, Jazz Pharmaceuticals, Merus NV, Hengrui Medicine, Sansheng Guojian, RemeGen Biopharma, Dizal (Jiangsu) Pharmaceutical

What are the Application segmentation covered in the ADCC Enhanced Antibody Market report?

Ans: The Applications covered in the ADCC Enhanced Antibody Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the ADCC Enhanced Antibody Market report?

Ans: The Types covered in the ADCC Enhanced Antibody Market report are Monospecific Antibody, Polyspecific Antibody, Fc Fusion Protein, Antibody Fusion Protein

1 ADCC Enhanced Antibody Market Overview

1.1 Product Definition

1.2 ADCC Enhanced Antibody by Type

1.2.1 Global ADCC Enhanced Antibody Market Value Comparison by Type (2024 VS 2031)

1.2.2 Monospecific Antibody

1.2.3 Polyspecific Antibody

1.2.4 Fc Fusion Protein

1.2.5 Antibody Fusion Protein

1.3 ADCC Enhanced Antibody by Application

1.3.1 Global ADCC Enhanced Antibody Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global ADCC Enhanced Antibody Market Size Estimates and Forecasts

1.4.1 Global ADCC Enhanced Antibody Revenue 2020-2031

1.4.2 Global ADCC Enhanced Antibody Sales 2020-2031

1.4.3 Global ADCC Enhanced Antibody Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 ADCC Enhanced Antibody Market Competition by Manufacturers

2.1 Global ADCC Enhanced Antibody Sales Market Share by Manufacturers (2020-2025)

2.2 Global ADCC Enhanced Antibody Revenue Market Share by Manufacturers (2020-2025)

2.3 Global ADCC Enhanced Antibody Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of ADCC Enhanced Antibody, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of ADCC Enhanced Antibody, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of ADCC Enhanced Antibody, Product Type & Application

2.7 Global Key Manufacturers of ADCC Enhanced Antibody, Date of Enter into This Industry

2.8 Global ADCC Enhanced Antibody Market Competitive Situation and Trends

2.8.1 Global ADCC Enhanced Antibody Market Concentration Rate

2.8.2 The Global 5 and 10 Largest ADCC Enhanced Antibody Players Market Share by Revenue

2.8.3 Global ADCC Enhanced Antibody Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global ADCC Enhanced Antibody Market Scenario by Region

3.1 Global ADCC Enhanced Antibody Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global ADCC Enhanced Antibody Sales by Region: 2020-2031

3.2.1 Global ADCC Enhanced Antibody Sales by Region: 2020-2025

3.2.2 Global ADCC Enhanced Antibody Sales by Region: 2026-2031

3.3 Global ADCC Enhanced Antibody Revenue by Region: 2020-2031

3.3.1 Global ADCC Enhanced Antibody Revenue by Region: 2020-2025

3.3.2 Global ADCC Enhanced Antibody Revenue by Region: 2026-2031

3.4 North America ADCC Enhanced Antibody Market Facts & Figures by Country

3.4.1 North America ADCC Enhanced Antibody Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America ADCC Enhanced Antibody Sales by Country (2020-2031)

3.4.3 North America ADCC Enhanced Antibody Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe ADCC Enhanced Antibody Market Facts & Figures by Country

3.5.1 Europe ADCC Enhanced Antibody Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe ADCC Enhanced Antibody Sales by Country (2020-2031)

3.5.3 Europe ADCC Enhanced Antibody Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific ADCC Enhanced Antibody Market Facts & Figures by Region

3.6.1 Asia Pacific ADCC Enhanced Antibody Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific ADCC Enhanced Antibody Sales by Region (2020-2031)

3.6.3 Asia Pacific ADCC Enhanced Antibody Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America ADCC Enhanced Antibody Market Facts & Figures by Country

3.7.1 Latin America ADCC Enhanced Antibody Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America ADCC Enhanced Antibody Sales by Country (2020-2031)

3.7.3 Latin America ADCC Enhanced Antibody Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa ADCC Enhanced Antibody Market Facts & Figures by Country

3.8.1 Middle East and Africa ADCC Enhanced Antibody Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa ADCC Enhanced Antibody Sales by Country (2020-2031)

3.8.3 Middle East and Africa ADCC Enhanced Antibody Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global ADCC Enhanced Antibody Sales by Type (2020-2031)

4.1.1 Global ADCC Enhanced Antibody Sales by Type (2020-2025)

4.1.2 Global ADCC Enhanced Antibody Sales by Type (2026-2031)

4.1.3 Global ADCC Enhanced Antibody Sales Market Share by Type (2020-2031)

4.2 Global ADCC Enhanced Antibody Revenue by Type (2020-2031)

4.2.1 Global ADCC Enhanced Antibody Revenue by Type (2020-2025)

4.2.2 Global ADCC Enhanced Antibody Revenue by Type (2026-2031)

4.2.3 Global ADCC Enhanced Antibody Revenue Market Share by Type (2020-2031)

4.3 Global ADCC Enhanced Antibody Price by Type (2020-2031)

5 Segment by Application

5.1 Global ADCC Enhanced Antibody Sales by Application (2020-2031)

5.1.1 Global ADCC Enhanced Antibody Sales by Application (2020-2025)

5.1.2 Global ADCC Enhanced Antibody Sales by Application (2026-2031)

5.1.3 Global ADCC Enhanced Antibody Sales Market Share by Application (2020-2031)

5.2 Global ADCC Enhanced Antibody Revenue by Application (2020-2031)

5.2.1 Global ADCC Enhanced Antibody Revenue by Application (2020-2025)

5.2.2 Global ADCC Enhanced Antibody Revenue by Application (2026-2031)

5.2.3 Global ADCC Enhanced Antibody Revenue Market Share by Application (2020-2031)

5.3 Global ADCC Enhanced Antibody Price by Application (2020-2031)

6 Key Companies Profiled

6.1 MacroGenics

6.1.1 MacroGenics Company Information

6.1.2 MacroGenics Description and Business Overview

6.1.3 MacroGenics ADCC Enhanced Antibody Sales, Revenue and Gross Margin (2020-2025)

6.1.4 MacroGenics ADCC Enhanced Antibody Product Portfolio

6.1.5 MacroGenics Recent Developments/Updates

6.2 Roche Holding AG

6.2.1 Roche Holding AG Company Information

6.2.2 Roche Holding AG Description and Business Overview

6.2.3 Roche Holding AG ADCC Enhanced Antibody Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Roche Holding AG ADCC Enhanced Antibody Product Portfolio

6.2.5 Roche Holding AG Recent Developments/Updates

6.3 Novartis AG

6.3.1 Novartis AG Company Information

6.3.2 Novartis AG Description and Business Overview

6.3.3 Novartis AG ADCC Enhanced Antibody Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Novartis AG ADCC Enhanced Antibody Product Portfolio

6.3.5 Novartis AG Recent Developments/Updates

6.4 C.H. Boehringer Sohn

6.4.1 C.H. Boehringer Sohn Company Information

6.4.2 C.H. Boehringer Sohn Description and Business Overview

6.4.3 C.H. Boehringer Sohn ADCC Enhanced Antibody Sales, Revenue and Gross Margin (2020-2025)

6.4.4 C.H. Boehringer Sohn ADCC Enhanced Antibody Product Portfolio

6.4.5 C.H. Boehringer Sohn Recent Developments/Updates

6.5 Puma Biotechnology

6.5.1 Puma Biotechnology Company Information

6.5.2 Puma Biotechnology Description and Business Overview

6.5.3 Puma Biotechnology ADCC Enhanced Antibody Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Puma Biotechnology ADCC Enhanced Antibody Product Portfolio

6.5.5 Puma Biotechnology Recent Developments/Updates

6.6 Pfizer

6.6.1 Pfizer Company Information

6.6.2 Pfizer Description and Business Overview

6.6.3 Pfizer ADCC Enhanced Antibody Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Pfizer ADCC Enhanced Antibody Product Portfolio

6.6.5 Pfizer Recent Developments/Updates

6.7 Daiichi Sankyo

6.7.1 Daiichi Sankyo Company Information

6.7.2 Daiichi Sankyo Description and Business Overview

6.7.3 Daiichi Sankyo ADCC Enhanced Antibody Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Daiichi Sankyo ADCC Enhanced Antibody Product Portfolio

6.7.5 Daiichi Sankyo Recent Developments/Updates

6.8 Takeda Pharmaceutical

6.8.1 Takeda Pharmaceutical Company Information

6.8.2 Takeda Pharmaceutical Description and Business Overview

6.8.3 Takeda Pharmaceutical ADCC Enhanced Antibody Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Takeda Pharmaceutical ADCC Enhanced Antibody Product Portfolio

6.8.5 Takeda Pharmaceutical Recent Developments/Updates

6.9 Jazz Pharmaceuticals

6.9.1 Jazz Pharmaceuticals Company Information

6.9.2 Jazz Pharmaceuticals Description and Business Overview

6.9.3 Jazz Pharmaceuticals ADCC Enhanced Antibody Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Jazz Pharmaceuticals ADCC Enhanced Antibody Product Portfolio

6.9.5 Jazz Pharmaceuticals Recent Developments/Updates

6.10 Merus NV

6.10.1 Merus NV Company Information

6.10.2 Merus NV Description and Business Overview

6.10.3 Merus NV ADCC Enhanced Antibody Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Merus NV ADCC Enhanced Antibody Product Portfolio

6.10.5 Merus NV Recent Developments/Updates

6.11 Hengrui Medicine

6.11.1 Hengrui Medicine Company Information

6.11.2 Hengrui Medicine Description and Business Overview

6.11.3 Hengrui Medicine ADCC Enhanced Antibody Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Hengrui Medicine ADCC Enhanced Antibody Product Portfolio

6.11.5 Hengrui Medicine Recent Developments/Updates

6.12 Sansheng Guojian

6.12.1 Sansheng Guojian Company Information

6.12.2 Sansheng Guojian Description and Business Overview

6.12.3 Sansheng Guojian ADCC Enhanced Antibody Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Sansheng Guojian ADCC Enhanced Antibody Product Portfolio

6.12.5 Sansheng Guojian Recent Developments/Updates

6.13 RemeGen Biopharma

6.13.1 RemeGen Biopharma Company Information

6.13.2 RemeGen Biopharma Description and Business Overview

6.13.3 RemeGen Biopharma ADCC Enhanced Antibody Sales, Revenue and Gross Margin (2020-2025)

6.13.4 RemeGen Biopharma ADCC Enhanced Antibody Product Portfolio

6.13.5 RemeGen Biopharma Recent Developments/Updates

6.14 Dizal (Jiangsu) Pharmaceutical

6.14.1 Dizal (Jiangsu) Pharmaceutical Company Information

6.14.2 Dizal (Jiangsu) Pharmaceutical Description and Business Overview

6.14.3 Dizal (Jiangsu) Pharmaceutical ADCC Enhanced Antibody Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Dizal (Jiangsu) Pharmaceutical ADCC Enhanced Antibody Product Portfolio

6.14.5 Dizal (Jiangsu) Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 ADCC Enhanced Antibody Industry Chain Analysis

7.2 ADCC Enhanced Antibody Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 ADCC Enhanced Antibody Production Mode & Process Analysis

7.4 ADCC Enhanced Antibody Sales and Marketing

7.4.1 ADCC Enhanced Antibody Sales Channels

7.4.2 ADCC Enhanced Antibody Distributors

7.5 ADCC Enhanced Antibody Customer Analysis

8 ADCC Enhanced Antibody Market Dynamics

8.1 ADCC Enhanced Antibody Industry Trends

8.2 ADCC Enhanced Antibody Market Drivers

8.3 ADCC Enhanced Antibody Market Challenges

8.4 ADCC Enhanced Antibody Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

C. H. Boehringer Sohn

Puma Biotechnology

Pfizer Inc

Daiichi Sankyo

Takeda Pharmaceutical

Dizal (Jiangsu) Pharmaceutical

List of Tables

Table 1. Global ADCC Enhanced Antibody Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global ADCC Enhanced Antibody Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global ADCC Enhanced Antibody Market Competitive Situation by Manufacturers in 2024

Table 4. Global ADCC Enhanced Antibody Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global ADCC Enhanced Antibody Sales Market Share by Manufacturers (2020-2025)

Table 6. Global ADCC Enhanced Antibody Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global ADCC Enhanced Antibody Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market ADCC Enhanced Antibody Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of ADCC Enhanced Antibody, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of ADCC Enhanced Antibody, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of ADCC Enhanced Antibody, Product Type & Application

Table 12. Global Key Manufacturers of ADCC Enhanced Antibody, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global ADCC Enhanced Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ADCC Enhanced Antibody as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global ADCC Enhanced Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global ADCC Enhanced Antibody Sales by Region (2020-2025) & (K Units)

Table 18. Global ADCC Enhanced Antibody Sales Market Share by Region (2020-2025)

Table 19. Global ADCC Enhanced Antibody Sales by Region (2026-2031) & (K Units)

Table 20. Global ADCC Enhanced Antibody Sales Market Share by Region (2026-2031)

Table 21. Global ADCC Enhanced Antibody Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global ADCC Enhanced Antibody Revenue Market Share by Region (2020-2025)

Table 23. Global ADCC Enhanced Antibody Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global ADCC Enhanced Antibody Revenue Market Share by Region (2026-2031)

Table 25. North America ADCC Enhanced Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America ADCC Enhanced Antibody Sales by Country (2020-2025) & (K Units)

Table 27. North America ADCC Enhanced Antibody Sales by Country (2026-2031) & (K Units)

Table 28. North America ADCC Enhanced Antibody Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America ADCC Enhanced Antibody Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe ADCC Enhanced Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe ADCC Enhanced Antibody Sales by Country (2020-2025) & (K Units)

Table 32. Europe ADCC Enhanced Antibody Sales by Country (2026-2031) & (K Units)

Table 33. Europe ADCC Enhanced Antibody Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe ADCC Enhanced Antibody Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific ADCC Enhanced Antibody Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific ADCC Enhanced Antibody Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific ADCC Enhanced Antibody Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific ADCC Enhanced Antibody Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific ADCC Enhanced Antibody Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America ADCC Enhanced Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America ADCC Enhanced Antibody Sales by Country (2020-2025) & (K Units)

Table 42. Latin America ADCC Enhanced Antibody Sales by Country (2026-2031) & (K Units)

Table 43. Latin America ADCC Enhanced Antibody Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America ADCC Enhanced Antibody Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa ADCC Enhanced Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa ADCC Enhanced Antibody Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa ADCC Enhanced Antibody Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa ADCC Enhanced Antibody Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa ADCC Enhanced Antibody Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global ADCC Enhanced Antibody Sales (K Units) by Type (2020-2025)

Table 51. Global ADCC Enhanced Antibody Sales (K Units) by Type (2026-2031)

Table 52. Global ADCC Enhanced Antibody Sales Market Share by Type (2020-2025)

Table 53. Global ADCC Enhanced Antibody Sales Market Share by Type (2026-2031)

Table 54. Global ADCC Enhanced Antibody Revenue (US$ Million) by Type (2020-2025)

Table 55. Global ADCC Enhanced Antibody Revenue (US$ Million) by Type (2026-2031)

Table 56. Global ADCC Enhanced Antibody Revenue Market Share by Type (2020-2025)

Table 57. Global ADCC Enhanced Antibody Revenue Market Share by Type (2026-2031)

Table 58. Global ADCC Enhanced Antibody Price (US$/Unit) by Type (2020-2025)

Table 59. Global ADCC Enhanced Antibody Price (US$/Unit) by Type (2026-2031)

Table 60. Global ADCC Enhanced Antibody Sales (K Units) by Application (2020-2025)

Table 61. Global ADCC Enhanced Antibody Sales (K Units) by Application (2026-2031)

Table 62. Global ADCC Enhanced Antibody Sales Market Share by Application (2020-2025)

Table 63. Global ADCC Enhanced Antibody Sales Market Share by Application (2026-2031)

Table 64. Global ADCC Enhanced Antibody Revenue (US$ Million) by Application (2020-2025)

Table 65. Global ADCC Enhanced Antibody Revenue (US$ Million) by Application (2026-2031)

Table 66. Global ADCC Enhanced Antibody Revenue Market Share by Application (2020-2025)

Table 67. Global ADCC Enhanced Antibody Revenue Market Share by Application (2026-2031)

Table 68. Global ADCC Enhanced Antibody Price (US$/Unit) by Application (2020-2025)

Table 69. Global ADCC Enhanced Antibody Price (US$/Unit) by Application (2026-2031)

Table 70. MacroGenics Company Information

Table 71. MacroGenics Description and Business Overview

Table 72. MacroGenics ADCC Enhanced Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. MacroGenics ADCC Enhanced Antibody Product

Table 74. MacroGenics Recent Developments/Updates

Table 75. Roche Holding AG Company Information

Table 76. Roche Holding AG Description and Business Overview

Table 77. Roche Holding AG ADCC Enhanced Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Roche Holding AG ADCC Enhanced Antibody Product

Table 79. Roche Holding AG Recent Developments/Updates

Table 80. Novartis AG Company Information

Table 81. Novartis AG Description and Business Overview

Table 82. Novartis AG ADCC Enhanced Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Novartis AG ADCC Enhanced Antibody Product

Table 84. Novartis AG Recent Developments/Updates

Table 85. C.H. Boehringer Sohn Company Information

Table 86. C.H. Boehringer Sohn Description and Business Overview

Table 87. C.H. Boehringer Sohn ADCC Enhanced Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. C.H. Boehringer Sohn ADCC Enhanced Antibody Product

Table 89. C.H. Boehringer Sohn Recent Developments/Updates

Table 90. Puma Biotechnology Company Information

Table 91. Puma Biotechnology Description and Business Overview

Table 92. Puma Biotechnology ADCC Enhanced Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Puma Biotechnology ADCC Enhanced Antibody Product

Table 94. Puma Biotechnology Recent Developments/Updates

Table 95. Pfizer Company Information

Table 96. Pfizer Description and Business Overview

Table 97. Pfizer ADCC Enhanced Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Pfizer ADCC Enhanced Antibody Product

Table 99. Pfizer Recent Developments/Updates

Table 100. Daiichi Sankyo Company Information

Table 101. Daiichi Sankyo Description and Business Overview

Table 102. Daiichi Sankyo ADCC Enhanced Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Daiichi Sankyo ADCC Enhanced Antibody Product

Table 104. Daiichi Sankyo Recent Developments/Updates

Table 105. Takeda Pharmaceutical Company Information

Table 106. Takeda Pharmaceutical Description and Business Overview

Table 107. Takeda Pharmaceutical ADCC Enhanced Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Takeda Pharmaceutical ADCC Enhanced Antibody Product

Table 109. Takeda Pharmaceutical Recent Developments/Updates

Table 110. Jazz Pharmaceuticals Company Information

Table 111. Jazz Pharmaceuticals Description and Business Overview

Table 112. Jazz Pharmaceuticals ADCC Enhanced Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Jazz Pharmaceuticals ADCC Enhanced Antibody Product

Table 114. Jazz Pharmaceuticals Recent Developments/Updates

Table 115. Merus NV Company Information

Table 116. Merus NV Description and Business Overview

Table 117. Merus NV ADCC Enhanced Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Merus NV ADCC Enhanced Antibody Product

Table 119. Merus NV Recent Developments/Updates

Table 120. Hengrui Medicine Company Information

Table 121. Hengrui Medicine Description and Business Overview

Table 122. Hengrui Medicine ADCC Enhanced Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Hengrui Medicine ADCC Enhanced Antibody Product

Table 124. Hengrui Medicine Recent Developments/Updates

Table 125. Sansheng Guojian Company Information

Table 126. Sansheng Guojian Description and Business Overview

Table 127. Sansheng Guojian ADCC Enhanced Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. Sansheng Guojian ADCC Enhanced Antibody Product

Table 129. Sansheng Guojian Recent Developments/Updates

Table 130. RemeGen Biopharma Company Information

Table 131. RemeGen Biopharma Description and Business Overview

Table 132. RemeGen Biopharma ADCC Enhanced Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. RemeGen Biopharma ADCC Enhanced Antibody Product

Table 134. RemeGen Biopharma Recent Developments/Updates

Table 135. Dizal (Jiangsu) Pharmaceutical Company Information

Table 136. Dizal (Jiangsu) Pharmaceutical Description and Business Overview

Table 137. Dizal (Jiangsu) Pharmaceutical ADCC Enhanced Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 138. Dizal (Jiangsu) Pharmaceutical ADCC Enhanced Antibody Product

Table 139. Dizal (Jiangsu) Pharmaceutical Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. ADCC Enhanced Antibody Distributors List

Table 143. ADCC Enhanced Antibody Customers List

Table 144. ADCC Enhanced Antibody Market Trends

Table 145. ADCC Enhanced Antibody Market Drivers

Table 146. ADCC Enhanced Antibody Market Challenges

Table 147. ADCC Enhanced Antibody Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Product Picture of ADCC Enhanced Antibody

Figure 2. Global ADCC Enhanced Antibody Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global ADCC Enhanced Antibody Market Share by Type: 2024 & 2031

Figure 4. Monospecific Antibody Product Picture

Figure 5. Polyspecific Antibody Product Picture

Figure 6. Fc Fusion Protein Product Picture

Figure 7. Antibody Fusion Protein Product Picture

Figure 8. Global ADCC Enhanced Antibody Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global ADCC Enhanced Antibody Market Share by Application: 2024 & 2031

Figure 10. Hospital

Figure 11. Clinic

Figure 12. Others

Figure 13. Global ADCC Enhanced Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global ADCC Enhanced Antibody Market Size (2020-2031) & (US$ Million)

Figure 15. Global ADCC Enhanced Antibody Sales (2020-2031) & (K Units)

Figure 16. Global ADCC Enhanced Antibody Average Price (US$/Unit) & (2020-2031)

Figure 17. ADCC Enhanced Antibody Report Years Considered

Figure 18. ADCC Enhanced Antibody Sales Share by Manufacturers in 2024

Figure 19. Global ADCC Enhanced Antibody Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest ADCC Enhanced Antibody Players: Market Share by Revenue in ADCC Enhanced Antibody in 2024

Figure 21. ADCC Enhanced Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global ADCC Enhanced Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America ADCC Enhanced Antibody Sales Market Share by Country (2020-2031)

Figure 24. North America ADCC Enhanced Antibody Revenue Market Share by Country (2020-2031)

Figure 25. United States ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe ADCC Enhanced Antibody Sales Market Share by Country (2020-2031)

Figure 28. Europe ADCC Enhanced Antibody Revenue Market Share by Country (2020-2031)

Figure 29. Germany ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific ADCC Enhanced Antibody Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific ADCC Enhanced Antibody Revenue Market Share by Region (2020-2031)

Figure 36. China ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. China Taiwan ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Southeast Asia ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America ADCC Enhanced Antibody Sales Market Share by Country (2020-2031)

Figure 44. Latin America ADCC Enhanced Antibody Revenue Market Share by Country (2020-2031)

Figure 45. Mexico ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Colombia ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Middle East and Africa ADCC Enhanced Antibody Sales Market Share by Country (2020-2031)

Figure 50. Middle East and Africa ADCC Enhanced Antibody Revenue Market Share by Country (2020-2031)

Figure 51. Turkey ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. UAE ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Global Sales Market Share of ADCC Enhanced Antibody by Type (2020-2031)

Figure 55. Global Revenue Market Share of ADCC Enhanced Antibody by Type (2020-2031)

Figure 56. Global ADCC Enhanced Antibody Price (US$/Unit) by Type (2020-2031)

Figure 57. Global Sales Market Share of ADCC Enhanced Antibody by Application (2020-2031)

Figure 58. Global Revenue Market Share of ADCC Enhanced Antibody by Application (2020-2031)

Figure 59. Global ADCC Enhanced Antibody Price (US$/Unit) by Application (2020-2031)

Figure 60. ADCC Enhanced Antibody Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions